Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
321
-
Total 13F shares, excl. options
-
123M
-
Shares change
-
+84.4K
-
Total reported value, excl. options
-
$4.54B
-
Value change
-
+$4.19M
-
Put/Call ratio
-
0.32
-
Number of buys
-
133
-
Number of sells
-
-147
-
Price
-
$37.02
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q2 2022
369 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q2 2022.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 321 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 123M shares
of 159M outstanding shares and own 77.38% of the company stock.
Largest 10 shareholders include FMR LLC (21.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (15.1M shares), VANGUARD GROUP INC (12.2M shares), Bellevue Group AG (9.78M shares), BlackRock Inc. (8.83M shares), Clearbridge Investments, LLC (6.01M shares), ARK Investment Management LLC (4.7M shares), STATE STREET CORP (4.2M shares), Tweedy, Browne Co LLC (2.73M shares), and Camber Capital Management LP (2.7M shares).
This table shows the top 321 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.